A cikin kwanan nan da aka buga binciken, masu bincike daga Jamhuriyar Czech sun ba da rahoton wani bincike da ba kasafai ba, na matakin kasa game da allurar rigakafin Covid da kuma mace-mace. Duk mai hankali ya kamata a kalla ya karanta abin koyi summary by Tomas Fürst akan Brownstone kuma yayi nazarin adadi a hankali.
Kusa da ƙarshen labarin Brownstone, Fürst ya rubuta:
"Duk da haka, a cikin madubi na Erised a sama, zaku iya ganin cewa maganin na iya bayyana yana da tasiri 80%, har ma da Covid-ba tare da dangantaka ba mutuwa! Har yanzu, ba mu sani ba wani Nazarin tasirin maganin rigakafi waɗanda suka yi ƙoƙarin gyara ga wannan babbar HVE [tasirin rigakafin lafiya, ES]. Wannan yana nufin cewa duk da'awar tasirin rigakafin Covid tun farkon kamfen ɗin rigakafin dole ne a sake fasalin. Tasirin ingancin maganin na gaskiya game da mutuwa daga Covid na iya zama sifili, ko ma mara kyau; ba mu sani ba kawai.”
Ba zan iya ƙara yarda ba. Maimaita tushen samfurin ikirarin kusan miliyoyin shekarun rayuwar da aka ceto ba za a iya daidaita su da ƙididdiga masu sauƙi na mace-mace-misali, sabanin Isra'ila da Sweden a cikin hunturu na 2020-2021 ko na farko worldwide lissafi. Bayan ya kasa shiga cikin ƙididdigewa injina na mujallun ilimin halittu, na sadaukar da posts da yawa ga lafiyayyen rigakafin son zuciya kuma a hanyar don cire shi. Koyaya, 'yan makonni bayan da aka buga binciken Czech, a ƙarshe na buga wani bita na tsara takarda akan (gyara) tasiri na rigakafin Covid. Hanyar bugawa ba ta da sauƙi. Ko da medRxiv ya ƙi saka takarda a kan wani uzuri na ban dariya. ("Ba labarin bincike na asibiti bane tare da sabbin bayanai.")
Yin amfani da bayanan da aka buga daga Qatar, na sami damar cire maɓalli biyu masu mahimmanci, ɗayansu shine tasirin rigakafin lafiya. Sauran son zuciya, da ake kira bisa ka'ida lokacin mutuwa, ya taso daga ban da abubuwan da suka faru a farkon alurar riga kafi, al'ada na yau da kullum na nazarin tasirin maganin rigakafi. Abin baƙin ciki, yana da fasaha da yawa don yin bayani a nan. Cire wannan son zuciya ya rage ƙididdiga na tasiri da yawa-wani lokaci daga sama da kashi 95 zuwa ƙasa da kashi 50-kuma yana ba da shawarar tasiri mara kyau da wuri.
Kamar yadda na bayyana a cikin a littafin (Babi na 37), ba za a iya kawar da rashin lafiyar alluran rigakafi ta hanyar daidaitacciyar hanya ba, don haka muna da zaɓuɓɓuka biyu: yarda da son zuciya ko ƙoƙarin cire ta ta hanyar da ba ta dace ba. A cikin nawa takarda, Na ba da hujja kuma na yi amfani da abubuwan gyara guda uku don kimanta tasirin rigakafin. Ana kiran shi bincike na hankali. Ƙarƙashin kowane gyara, tasiri a kan sakamako mai tsanani na bambance-bambancen farko guda biyu mara kyau a cikin wata na farko kuma kusa da sifili, a mafi kyau, lokacin da aka kai cikakkiyar rigakafi. Takardar asali ta ba da rahoton tasiri 100%…
Lokacin dawwama da lafiyayyen rigakafin ba shine kawai son rai ba a cikin binciken lura na rigakafin Covid. Aƙalla ya kamata a ambaci ƙarin biyu:
Mutanen da aka yi wa allurar ba su da yuwuwar a gwada su ga Covid fiye da takwarorinsu da ba a yi musu allurar ba, don haka, ba za a iya rarraba su a matsayin shari'o'in mutuwar Covid da Covid. A cikin taxonomy na son zuciya, ana kiransa son zuciya. Muna da shaida mara tantama cewa son zuciya yana aiki a cikin Isra'ila-"Labbin Pfizer" -a lokacin yakin neman rigakafin farko. Wataƙila wannan son zuciya ya shafi nazari daga ƙasashe da yawa.
Wani tushen son zuciya shine lokaci na kamfen ɗin rigakafin, wanda galibi ya zo daidai da igiyar Covid. A sakamakon haka, lokacin da ke cikin haɗari a cikin yanayin da ba a yi amfani da shi ba ya mayar da hankali ne a lokacin karuwar yawan kamuwa da cuta, yayin da lokacin da ke cikin haɗari a cikin yanayin alurar riga kafi ya mayar da hankali a lokacin raguwa. Ana kiran shi rikicewa ta hanyar yanayin lokaci a cikin haɗarin sakamakon. Wasu ƴan bincike sun yi ƙoƙarin hana wannan son zuciya ta hanyar daidaitawa akan lokacin kalanda; da yawa ba su yi ba.
Cikakken guguwa na son zuciya yana aiki a wancan lokacin, kuma, kamar yadda Fürst ya rubuta, "Mahimman ƙimar tasirin maganin alurar riga kafi ba za a iya samu ba ne kawai daga binciken da ba a iya gani ba."
Ina mamakin ko zamu taba ganinsu. Shin FDA za ta ci gaba da ba da izini ga sabbin rigakafin mRNA Covid kowace shekara dangane da ikonsu na samar da ƙwayoyin cuta? Wataƙila muna ƙara haɗarin kamuwa da cuta tare da ƙarin harbi saboda canza aji zuwa IgG4 antibodies? Ya kamata a ci gaba da gudanar da waɗannan harbe-harbe ga mazauna gidajen kulawa, idan mummunan tasiri shi ne akalla zai yiwu, kuma mace-mace masu alaka da allurar rigakafi babu shakka ya faru? Shin yana da da'a don ci gaba da amincewa da sabon salon jiyya? ba tare da gwaji guda ɗaya, ingantaccen tsari, bazuwar gwaji tare da ƙarshen mace-mace?
FDA, a ƙarƙashin sabuwar gwamnati, kwanan nan ta yi ci gaba a hanya madaidaiciya. Ina fata ba za su tsaya nan ba. Winter ya yi kusa da gwaji a wannan shekara, amma akwai yalwar lokaci don NIH don rubuta Buƙatun Aikace-aikace don gwajin bazuwar hunturu na gaba. Yawan karatun yakamata su kasance mazauna gidajen kulawa waɗanda zasu iya ba da izini saboda wannan shine yawan jama'a masu haɗari. Bari mu ga kwatancen ƙirar shekara mai zuwa na rigakafin mRNA Covid tare da placebo, tare da ƙarshen mace-mace: Mutuwar Covid da kuma duk- sanadin mutuwa. Wataƙila ya kamata a sami hannu na uku don mura mura.
-
Dokta Eyal Shahar farfesa ne a fannin kiwon lafiyar jama'a a fannin cututtukan cututtuka da kididdiga. Binciken nasa yana mayar da hankali ne akan ilimin cututtuka da kuma hanyoyin. A cikin 'yan shekarun nan, Dr. Shahar ya ba da gudummawa sosai ga hanyoyin bincike, musamman a fannin zane-zane da kuma son zuciya.
Duba dukkan posts
